Why Flexible, Collaborative Distribution Partners Matter For Cell And Gene Therapies

Traditional inventory models fall short for cell and gene therapies, where the complexity of drop-shipment and reimbursement volatility requires a more agile approach. Success depends on selecting partners with dedicated expertise who can navigate the nuances of order-based fulfillment rather than standard inventory management. Flexibility is paramount; distributors must adapt payment terms and workflows to match differing site-of-care readiness and evolving payer requirements. Beyond logistics, a synchronized ecosystem involving specialty pharmacies and couriers ensures product integrity and financial stability for providers.

Aligning these stakeholders early in the pre-launch phase minimizes administrative friction and secures the path to commercialization. Explore the strategies for building a collaborative distribution network by reading the full article.